$13.23
-0.56 (-4.06%)
Open$13.75
Previous Close$13.79
Day High$13.86
Day Low$13.11
52W High$19.11
52W Low$3.91
Volume—
Avg Volume2.07M
Market Cap1.22B
P/E Ratio—
EPS$-2.99
SectorPharmaceuticals
Analyst Ratings
Strong Buy
18 analysts
Price Target
-30.4% upside
Current
$13.23
$13.23
Target
$9.21
$9.21
$6.71
$9.21 avg
$14.14
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 61.99M | 58.80M | 211.34M |
| Net Income | -187,473,367 | -160,051,252 | 52.60M |
| Profit Margin | -302.4% | -287.3% | 24.9% |
| EBITDA | -206,732,009 | -186,298,054 | 60.54M |
| Free Cash Flow | — | — | 38.74M |
| Rev Growth | +5.4% | +5.4% | -6.2% |
| Debt/Equity | — | — | 0.26 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |